2-aminopurine has been researched along with Chronic Hepatitis B in 59 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 18 (30.51) | 18.2507 |
2000's | 41 (69.49) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cheng, CT; Garrido-Lestache, S; Hui, CK; Lai, CL; Lai, YP; Yuen, MF | 1 |
Colak, H; Demirtürk, N; Dinçer, S; Kartal, ED; Ozgünes, I; Usluer, G | 1 |
Dimou, E; Papadimitropoulos, V; Papatheodoridis, GV | 1 |
Guan, R; Kajiji, T; Lim, SG; Rajnakova, A; Wai, CT | 1 |
de Man, RA; Hansen, BE; Niesters, HG; Wolters, LM | 1 |
Benesch, M; Deutsch, J; Dornbusch, HJ; Kerbl, R; Kessler, HH; Lackner, H; Moser, A; Schwinger, W; Sovinz, P; Urban, C | 1 |
Ji, D; Li, L; Shao, Q; Zhang, J | 1 |
Ayres, A; Bartholomeusz, A; Lam, KC; Lau, G; Lee, JY; Locarnini, S | 1 |
Ji, W; Li, L; Su, HB; Wang, HF | 1 |
Ozden, N; Saruc, M; Yuceyar, H | 1 |
Lagget, M; Rizzetto, M | 1 |
Arnold, E; Das, K; Delaney, WE; Gibbs, CS; Miller, MD; Westland, CE; Xiong, S; Yang, H | 1 |
Echevarría, JM; León, P; Pozo, F | 1 |
Alsatie, M; Chalasani, N; Eckert, G; Kwo, PY; Lumeng, L; Shen, H | 1 |
Berr, F; Etzrodt, G; Klecker, C; Liebert, UG; Maier, M; Oesen, U; Schiefke, I; Tannapfel, A | 1 |
Avci, A; Erhardt, A; Häussinger, D; Heintges, T; Lörke, J; Sagir, A | 1 |
Guo, SH; Lu, WL; Ren, H; Sun, JY; Wang, ZY; Xu, DZ; Yao, JL; Zhang, DF; Zhao, YR; Zhou, XQ | 1 |
Bara, C; Böker, KH; Deterding, K; Haverich, A; Manns, MP; Meyer, S; Pethig, K; Potthoff, A; Tillmann, HL; Wedemeyer, H | 1 |
Bode, U; Böker, KH; Broelsch, CE; Krüger, M; Manns, MP; Maschek, H; Oldhafer, K; Pichlmayr, R; Tillmann, HL; Trautwein, C | 1 |
Angus, P; Bowden, S; Breschkin, A; Locarnini, S; McCaughan, G; Shaw, T; Sheil, R | 1 |
Tassopoulos, NC | 1 |
Córdoba Cortijo, J; López Viedma, B; Olaso Peiró, V | 1 |
de Man, RA; Honkoop, P; Niesters, HG; Wolters, LM | 1 |
Jaeckel, E; Manns, MP | 1 |
Hoofnagle, JH; Lau, DT; Marques, AR; McKenzie, R; Straus, SE | 1 |
Lavanchy, D; Renner, EL | 1 |
Pichoud, C; Seignères, B; Trépo, C; Wang, Z; Zoulim, F | 1 |
Main, J; McCarron, B; Thomas, HC | 1 |
Carman, WF; Lam, SK; Lau, GK; Locarnini, SA; Lu, ZM; Okuda, K; Williams, R | 1 |
Au, WY; Lau, GK; Liang, R; Wu, PC; Yuen, ST | 1 |
Bechstein, WO; Budde, K; Hocher, B; Krüger, DH; Meisel, H; Neuhaus, P; Neumayer, HH; Preikschat, P; Reinke, P | 1 |
Trepo, C; Zoulim, F | 1 |
Young, CL | 1 |
Hultgren, C; Milich, DR; Sällberg, M; Weiland, O | 1 |
Bastürk, M; Böker, KH; Flemming, P; Goldmann, E; Griffin, KE; Haverich, A; Manns, MP; Pethig, K; Petzold, DR; Tillmann, HL; Vollmar, J; Wedemeyer, H | 1 |
Berby, F; Petit, MA; Pichoud, C; Stuyver, L; Trépo, C; Zoulim, F | 1 |
Ahmed, SS; Hantz, O; Pichoud, C; Seignères, B; Trépo, C; Zoulim, F | 1 |
Freiman, JS; McCaughan, GW | 1 |
Cote, P; Gerin, JL; Hornbuckle, W; Korba, BE; Schinazi, R; Tennant, BC | 1 |
Airoldi, A; Pinzello, G; Zavaglia, C | 1 |
Cote, P; Gerin, JL; Hornbuckle, W; Korba, BE; Tennant, BC | 1 |
Fen, X; Hou, J; Nie, Z | 1 |
Atkinson, G; Boon, R; Jezek, P; Trépo, C; Young, C | 1 |
Carman, WF; Gibbs, CS; Hou, J; Lam, S; Lau, GK; Tsiang, M; Yuen, S; Zhang, L | 1 |
de Man, RA; Desmond, P; Habal, F; Jurewicz, R; Marcellin, P; Rose, T; Wright, T; Young, C | 1 |
Locarnini, S; Shaw, T | 1 |
Leung, N | 1 |
Abidi, H; Ahmed, S; Berby, F; Johnson, M; Merle, P; Nafa, S; Pichoud, C; Stuyver, L; Tavan, D; Trépo, C; Zoulim, F | 1 |
Bechstein, WO; Berg, T; Hopf, U; Langrehr, JM; Müller, AR; Naumann, U; Neuhaus, P; Neuhaus, R; Platz, KP; Rayes, N; Seehofer, D; Steinmüller, T | 1 |
Bechstein, WO; Berg, T; Müller, AR; Neuhaus, P; Neuhaus, R; Rayes, N; Seehofer, D | 1 |
Grande Santamaría, L; Romero Gómez, M; Suárez García, E | 1 |
Forns, X; Sánchez-Tapias, JM | 1 |
Fried, MW; Sommadossi, JP | 1 |
Lau, GK | 1 |
Bar-Nathan, N; Ben-Ari, Z; Dinari, G; Mor, E; Shapira, R; Sokal, EM; Tur-Kaspa, R | 1 |
de Man, RA; Niesters, HG; Wolters, LM | 1 |
Perrillo, RP | 1 |
Di Bisceglie, AM | 1 |
Au, WS; Fong, DY; Hou, J; Kung, HF; Lam, SK; Lau, GK; Lin, M; Nanji, A; Yuen, ST | 1 |
17 review(s) available for 2-aminopurine and Chronic Hepatitis B
Article | Year |
---|---|
Nucleoside analogues for chronic hepatitis B: antiviral efficacy and viral resistance.
Topics: 2-Aminopurine; Antiviral Agents; Cross Reactions; Drug Resistance, Viral; Famciclovir; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Nucleosides; Reverse Transcriptase Inhibitors; Virus Replication | 2002 |
Thymosin in the treatment of HBeAg-negative chronic hepatitis B.
Topics: 2-Aminopurine; Antiviral Agents; Drug Therapy, Combination; Famciclovir; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Interferons; Lamivudine; Reverse Transcriptase Inhibitors; Thymosin | 2003 |
Current pharmacotherapy for the treatment of chronic hepatitis B.
Topics: 2-Aminopurine; Adenine; Antiviral Agents; Clinical Trials as Topic; Famciclovir; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferons; Lamivudine; Liver Transplantation; Mutation; Nucleosides; Organophosphonates | 2003 |
[New approaches in the treatment of hepatitis B].
Topics: 2-Aminopurine; Adenine; Antiviral Agents; Arabinofuranosyluracil; Carcinoma, Hepatocellular; Contraindications; Deoxycytidine; Emtricitabine; Famciclovir; Guanine; Hepatitis B, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Liver Neoplasms; Organophosphonates; Organophosphorus Compounds; Polyethylene Glycols; Prodrugs; Prognosis; Recombinant Proteins; Tenofovir; Zalcitabine | 2004 |
Chronic hepatitis B: interferon-monotherapy or combination with nucleoside analogues?
Topics: 2-Aminopurine; Antiviral Agents; Drug Therapy, Combination; Famciclovir; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine; Reverse Transcriptase Inhibitors | 1998 |
[New antiviral agents in the treatment of chronic hepatitis B and C].
Topics: 2-Aminopurine; Antimetabolites; Antiviral Agents; Clinical Trials as Topic; Famciclovir; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Lamivudine; Prodrugs; Reverse Transcriptase Inhibitors; Ribavirin | 1998 |
Experience with lamivudine against hepatitis B virus.
Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Famciclovir; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunocompromised Host; Interferons; Lamivudine; Liver Transplantation; Mutation; Nucleosides; Reverse Transcriptase Inhibitors | 1997 |
Treatment of chronic viral hepatitis.
Topics: 2-Aminopurine; Animals; Antimetabolites; Antiviral Agents; Carcinoma, Hepatocellular; Disease Models, Animal; Drug Therapy, Combination; Ducks; Famciclovir; Female; Hepatitis B, Chronic; Hepatitis C, Chronic; Hepatitis, Animal; Humans; Immunologic Factors; Interferon-alpha; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Male; Marmota; Poultry Diseases; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Tumor Cells, Cultured | 1998 |
New antiviral agents for the therapy of chronic hepatitis B virus infection.
Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Clinical Trials as Topic; Drug Resistance, Microbial; Drug Therapy, Combination; Famciclovir; Hepatitis B, Chronic; Humans; Lamivudine; Virus Replication | 1999 |
Famciclovir update. Chronic hepatitis B.
Topics: 2-Aminopurine; Antiviral Agents; Clinical Trials, Phase II as Topic; Famciclovir; Hepatitis B, Chronic; Humans; Liver Transplantation; Prodrugs; Recurrence | 1999 |
Current limitations to nucleoside analogue therapy for chronic hepatitis B virus infection in the liver transplant and non-transplant settings.
Topics: 2-Aminopurine; Adenine; Antiviral Agents; DNA, Viral; Famciclovir; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Transplantation; Organophosphonates; Treatment Outcome | 2000 |
Antiviral therapy of HBV- and HCV-induced liver cirrhosis.
Topics: 2-Aminopurine; Antiviral Agents; Clinical Trials as Topic; Famciclovir; Female; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon-alpha; Lamivudine; Liver Cirrhosis; Male; Prognosis; Reverse Transcriptase Inhibitors; Survival Rate; Thymalfasin; Thymosin; Treatment Outcome | 2000 |
Nucleoside analogues in the treatment of chronic hepatitis B.
Topics: 2-Aminopurine; Adenine; Antiviral Agents; Deoxycytidine; Emtricitabine; Famciclovir; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Nucleosides; Organophosphonates | 2000 |
Nucleoside analogues and other investigational modalities for the treatment of chronic hepatitis B.
Topics: 2-Aminopurine; Animals; Antiviral Agents; Arabinofuranosyluracil; Clinical Trials as Topic; Combined Modality Therapy; Dideoxynucleosides; Famciclovir; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Transplantation; Reverse Transcriptase Inhibitors; Ribavirin; Vidarabine | 1996 |
Hepatitis B infection in China.
Topics: 2-Aminopurine; Adenine; Antiviral Agents; China; Deoxycytidine; DNA, Viral; Drug Therapy, Combination; Drugs, Chinese Herbal; Emtricitabine; Famciclovir; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine; Organophosphonates; Thymosin | 2001 |
Nucleoside analogues for chronic hepatitis B.
Topics: 2-Aminopurine; Adenine; Antiviral Agents; Famciclovir; Ganciclovir; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Organophosphonates; Reverse Transcriptase Inhibitors | 2001 |
How will we use the new antiviral agents for hepatitis B?
Topics: 2-Aminopurine; Adenine; Alanine Transaminase; Antiviral Agents; Drug Resistance; Drug Therapy, Combination; Famciclovir; Ganciclovir; Gene Products, pol; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine; Mutation; Organophosphonates; Practice Guidelines as Topic | 2002 |
16 trial(s) available for 2-aminopurine and Chronic Hepatitis B
Article | Year |
---|---|
Comparison of the efficacy of lamivudine and famciclovir in Asian patients with chronic hepatitis B: results of 24 weeks of therapy.
Topics: 2-Aminopurine; Adolescent; Adult; Antiviral Agents; China; DNA, Viral; Famciclovir; Female; Hepatitis B Antibodies; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Treatment Outcome | 2002 |
Comparison of different treatment combinations for chronic hepatitis B infection.
Topics: 2-Aminopurine; Adolescent; Adult; Aged; Antiviral Agents; DNA, Viral; Drug Administration Schedule; Drug Therapy, Combination; Famciclovir; Female; Hepatitis B Vaccines; Hepatitis B virus; Hepatitis B, Chronic; Humans; Injections, Intramuscular; Injections, Subcutaneous; Interferon-alpha; Lamivudine; Male; Middle Aged; Treatment Outcome | 2002 |
Viral dynamics in chronic hepatitis B patients treated with lamivudine, lamivudine-famciclovir or lamivudine-ganciclovir.
Topics: 2-Aminopurine; Adult; Antiviral Agents; Drug Therapy, Combination; Famciclovir; Female; Ganciclovir; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Models, Theoretical; Reverse Transcriptase Inhibitors; Virus Replication | 2002 |
Serological and molecular response on combined antiviral treatment in children with chronic hepatitis B after pediatric malignancy.
Topics: 2-Aminopurine; Adolescent; Antiviral Agents; Child; Child, Preschool; DNA, Viral; Drug Therapy, Combination; Evaluation Studies as Topic; Famciclovir; Female; Hematologic Neoplasms; Hepatitis B, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Prednisone; Recombinant Proteins; Safety; Serotyping; Treatment Outcome | 2002 |
[Famciclovir treatment of patients with chronic hepatitis B virus infection].
Topics: 2-Aminopurine; Adolescent; Aged; Antiviral Agents; Famciclovir; Female; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine; Male; Middle Aged; Treatment Outcome | 2002 |
Combination therapy with lamivudine and famciclovir for chronic hepatitis B infection.
Topics: 2-Aminopurine; Adult; Aged; Antiviral Agents; DNA, Viral; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Famciclovir; Female; Follow-Up Studies; Hepatitis B, Chronic; Humans; Lamivudine; Liver Function Tests; Male; Middle Aged; Pilot Projects; Risk Assessment; Severity of Illness Index; Treatment Outcome; Viral Load | 2004 |
Sequential combination therapy of HBe antigen-negative/virus-DNA-positive chronic hepatitis B with famciclovir or lamivudine and interferon-alpha-2a.
Topics: 2-Aminopurine; Administration, Oral; Adolescent; Adult; Aged; Alanine Transaminase; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Famciclovir; Female; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Injections, Subcutaneous; Interferon alpha-2; Interferon-alpha; Lamivudine; Male; Middle Aged; Mutation; Recombinant Proteins; Treatment Outcome; Viral Load; Viremia | 2004 |
[Clinical investigation of famciclovir in chronic hepatitis B patients irresponsive to alpha interferon treatment].
Topics: 2-Aminopurine; Adolescent; Adult; Antiviral Agents; Double-Blind Method; Famciclovir; Female; Follow-Up Studies; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Treatment Outcome; Virus Replication | 2005 |
Famciclovir treatment of hepatitis B virus recurrence after liver transplantation: a pilot study.
Topics: 2-Aminopurine; Adult; Aged; Alanine Transaminase; Antiviral Agents; DNA, Viral; Famciclovir; Female; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunosuppression Therapy; Liver Transplantation; Male; Middle Aged; Pilot Projects; Prognosis; Recurrence; Treatment Outcome | 1996 |
Combination therapy with famciclovir and interferon-alpha for the treatment of chronic hepatitis B.
Topics: 2-Aminopurine; Adult; Alanine Transaminase; Antiviral Agents; Aspartate Aminotransferases; DNA, Viral; Drug Therapy, Combination; Famciclovir; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon-alpha; Male | 1998 |
Famciclovir treatment of chronic hepatitis B in heart transplant recipients: a prospective trial.
Topics: 2-Aminopurine; Adult; Aged; Alanine Transaminase; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Famciclovir; Female; Heart Transplantation; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunosuppressive Agents; Male; Middle Aged; Postoperative Complications; Prodrugs; Prospective Studies; Time Factors | 1999 |
Evolution of hepatitis B virus polymerase gene sequence during famciclovir therapy for chronic hepatitis B.
Topics: 2-Aminopurine; Adult; Amino Acid Sequence; Antiviral Agents; Cloning, Molecular; Drug Resistance, Microbial; Evolution, Molecular; Famciclovir; Female; Gene Products, pol; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Longitudinal Studies; Male; Middle Aged; Molecular Sequence Data; RNA-Directed DNA Polymerase; Sequence Alignment | 2000 |
Famciclovir in chronic hepatitis B: results of a dose-finding study.
Topics: 2-Aminopurine; Adult; Alanine Transaminase; Antiviral Agents; DNA, Viral; Dose-Response Relationship, Drug; Double-Blind Method; Famciclovir; Female; Hepacivirus; Hepatitis Antibodies; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Male; Middle Aged; Treatment Outcome; Virus Replication | 2000 |
Combination therapy with lamivudine and famciclovir for chronic hepatitis B-infected Chinese patients: a viral dynamics study.
Topics: 2-Aminopurine; Adolescent; Adult; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Famciclovir; Female; Follow-Up Studies; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged | 2000 |
A randomized, placebo-controlled study to evaluate the efficacy of 12-month famciclovir treatment in patients with chronic hepatitis B e antigen-positive hepatitis B.
Topics: 2-Aminopurine; Adolescent; Adult; Aged; Alanine Transaminase; DNA, Viral; Double-Blind Method; Famciclovir; Female; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Liver; Male; Middle Aged | 2000 |
Thymosin-alpha1 and famciclovir combination therapy activates T-cell response in patients with chronic hepatitis B virus infection in immune-tolerant phase.
Topics: 2-Aminopurine; Adjuvants, Immunologic; Adolescent; Adult; Antiviral Agents; Cell Division; Cells, Cultured; Cytokines; DNA, Viral; Drug Therapy, Combination; Famciclovir; Female; Hepatitis B Core Antigens; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immune Tolerance; Male; Middle Aged; T-Lymphocytes; Thymalfasin; Thymosin; Time Factors | 2002 |
26 other study(ies) available for 2-aminopurine and Chronic Hepatitis B
Article | Year |
---|---|
Fatal hepatitis B reactivation following discontinuation of nucleoside analogues for chronic hepatitis B.
Topics: 2-Aminopurine; Adult; Aged; Alanine Transaminase; Antiviral Agents; Bilirubin; DNA, Viral; Drug Resistance, Viral; Famciclovir; Fatal Outcome; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Mutation; Recurrence; Virus Activation | 2002 |
Lamivudine and Famciclovir resistant hepatitis B virus associated with fatal hepatic failure.
Topics: 2-Aminopurine; Adult; Antiviral Agents; Drug Resistance, Viral; Drug Therapy, Combination; Famciclovir; Fatal Outcome; Female; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Failure; Reverse Transcriptase Inhibitors | 2003 |
[Treatment of patients with chronic hepatitis B virus infect ion with lamivudine combined with famciclovir].
Topics: 2-Aminopurine; Adolescent; Adult; Aged; Antiviral Agents; Child; Drug Therapy, Combination; Famciclovir; Female; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged | 2003 |
The hepatitis B virus polymerase mutation rtV173L is selected during lamivudine therapy and enhances viral replication in vitro.
Topics: 2-Aminopurine; Amino Acid Sequence; Antiviral Agents; Drug Resistance, Viral; Famciclovir; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Microbial Sensitivity Tests; Models, Molecular; Molecular Sequence Data; Mutation; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Selection, Genetic; Virus Replication | 2003 |
Detection of hepatitis B virus variants resistant to lamivudine and famciclovir among randomly selected chronic carriers from Spain.
Topics: 2-Aminopurine; Amino Acid Sequence; Antiviral Agents; Diagnostic Tests, Routine; DNA Mutational Analysis; DNA, Viral; Drug Resistance, Multiple, Viral; Famciclovir; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Microbial Sensitivity Tests; Molecular Sequence Data; Point Mutation; Retrospective Studies; RNA-Directed DNA Polymerase; Spain | 2004 |
Improved outcome of chronic hepatitis B after heart transplantation by long-term antiviral therapy.
Topics: 2-Aminopurine; Adult; Aged; Antiviral Agents; Carcinoma, Hepatocellular; Famciclovir; Female; Heart Transplantation; Hepatitis B, Chronic; Humans; Immunosuppressive Agents; Lamivudine; Liver Neoplasms; Male; Middle Aged | 2006 |
Retransplantation for precore mutant-related chronic hepatitis B infection: prolonged survival in a patient receiving sequential ganciclovir/famciclovir therapy.
Topics: 2-Aminopurine; Antiviral Agents; DNA, Viral; Famciclovir; Follow-Up Studies; Ganciclovir; Graft Rejection; Graft Survival; Hepatitis B virus; Hepatitis B, Chronic; Humans; Liver Cirrhosis; Liver Function Tests; Liver Transplantation; Male; Middle Aged; Reoperation | 1996 |
Efficacy of famciclovir treatment in chronic hepatitis B patients with different mutations at position 552 of the DNA polymerase gene.
Topics: 2-Aminopurine; Alanine Transaminase; Antiviral Agents; DNA-Directed DNA Polymerase; DNA, Viral; Famciclovir; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Point Mutation; Prodrugs | 1998 |
[Drug therapy of chronic hepatitis B].
Topics: 2-Aminopurine; Antiviral Agents; Famciclovir; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine; Reverse Transcriptase Inhibitors; Treatment Outcome; Virus Replication | 1998 |
Transient selection of a hepatitis B virus polymerase gene mutant associated with a decreased replication capacity and famciclovir resistance.
Topics: 2-Aminopurine; Adult; Amino Acid Sequence; Antiviral Agents; Biomarkers; Cells, Cultured; Cloning, Molecular; DNA-Directed DNA Polymerase; Drug Resistance, Microbial; Famciclovir; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunocompetence; Male; Molecular Sequence Data; Mutation; Prodrugs; Transfection; Virus Replication | 1999 |
Treatment of chronic hepatitis B virus infection: an Asia-Pacific perspective.
Topics: 2-Aminopurine; Adjuvants, Immunologic; Animals; Antiviral Agents; Asia; Drug Therapy, Combination; Famciclovir; Hepatitis B Vaccines; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Pacific Islands; Vaccines, DNA | 1999 |
Histological changes during clearance of chronic hepatitis B virus infection by adoptive immunity transfer.
Topics: 2-Aminopurine; Adolescent; Adult; Antiviral Agents; Bone Marrow Transplantation; Famciclovir; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Liver; Male | 1999 |
Disappearance of hepatitis B virus core deletion mutants and successful combined kidney/liver transplantation in a patient treated with lamivudine.
Topics: 2-Aminopurine; Antiviral Agents; DNA, Viral; Famciclovir; Follow-Up Studies; Genetic Variation; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunosuppressive Agents; Kidney Transplantation; Lamivudine; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Mutation; Renal Dialysis; Sequence Deletion | 1999 |
Cell-mediated immune responses and loss of hepatitis B e-antigen (HBeAg) during successful lamivudine and famciclovir combination therapy for chronic replicating hepatitis B virus infection.
Topics: 2-Aminopurine; Aged; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Famciclovir; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunity, Cellular; Lamivudine; Male; Treatment Outcome; Virus Replication | 1999 |
Persistence of viral replication after anti-HBe seroconversion during antiviral therapy for chronic hepatitis B.
Topics: 2-Aminopurine; Antibodies, Viral; Antiviral Agents; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Famciclovir; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine; Virus Replication | 2000 |
Enhanced antiviral benefit of combination therapy with lamivudine and famciclovir against WHV replication in chronic WHV carrier woodchucks.
Topics: 2-Aminopurine; Animals; Antiviral Agents; Carrier State; Disease Models, Animal; Drug Therapy, Combination; Famciclovir; Hepatitis B Virus, Woodchuck; Hepatitis B, Chronic; Lamivudine; Marmota; Prodrugs; Reverse Transcriptase Inhibitors; Viremia; Virus Replication | 2000 |
Treatment of chronic woodchuck hepatitis virus infection in the Eastern woodchuck (Marmota monax) with nucleoside analogues is predictive of therapy for chronic hepatitis B virus infection in humans.
Topics: 2-Aminopurine; Animals; Antiviral Agents; Famciclovir; Hepatitis B Virus, Woodchuck; Hepatitis B, Chronic; Humans; Marmota; Ribavirin; Vidarabine Phosphate; Virus Replication; Zidovudine | 2000 |
[Dynamic changes of hepatitis B virus during treatment with lamivudine versus lamivudine plus famciclovir].
Topics: 2-Aminopurine; Adolescent; Adult; Antiviral Agents; Drug Therapy, Combination; Famciclovir; Female; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Virus Replication | 2000 |
Combination chemotherapy for hepatitis B virus: the final solution?
Topics: 2-Aminopurine; Antiviral Agents; DNA, Viral; Drug Resistance; Drug Therapy, Combination; Famciclovir; Hepatitis B, Chronic; Humans; Lamivudine | 2000 |
Early detection of viral resistance by determination of hepatitis B virus polymerase mutations in patients treated by lamivudine for chronic hepatitis B.
Topics: 2-Aminopurine; Adolescent; Adult; Aged; Aged, 80 and over; DNA, Viral; Drug Resistance, Microbial; Drug Therapy, Combination; Famciclovir; Female; Gene Products, pol; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine; Male; Middle Aged; Mutation; Recombinant Proteins; Retreatment; Reverse Transcriptase Inhibitors | 2000 |
[Therapy of recurrent hepatitis B infection after liver transplantation. A retrospective analysis of 200 liver transplantations based on hepatitis B associated liver diseases].
Topics: 2-Aminopurine; Adult; Antiviral Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Famciclovir; Female; Hepatitis B, Chronic; Humans; Immunization, Passive; Interferon alpha-2; Interferon-alpha; Lamivudine; Liver Transplantation; Male; Middle Aged; Recombinant Proteins; Recurrence; Retrospective Studies; Survival Rate; Treatment Outcome | 2000 |
Antiviral combination therapy for lamivudine-resistant hepatitis B reinfection after liver transplantation.
Topics: 2-Aminopurine; Alanine Transaminase; Antiviral Agents; DNA, Viral; Drug Resistance, Microbial; Drug Therapy, Combination; Famciclovir; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Liver Transplantation; Middle Aged; Postoperative Complications; Recombinant Proteins; Recurrence; Retrospective Studies; Time Factors; Virus Replication | 2000 |
[Current treatment of hepatitis B].
Topics: 2-Aminopurine; Adenine; Anti-Inflammatory Agents; Antiviral Agents; DNA Replication; Famciclovir; Forecasting; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine; Organophosphonates; Prednisone; Prognosis; Reverse Transcriptase Inhibitors; Time Factors; Virus Replication | 2001 |
[Laboratory diagnosis of hepatitis B].
Topics: 2-Aminopurine; Acute Disease; Antiviral Agents; DNA Replication; DNA, Viral; Drug Resistance; Famciclovir; Genetic Variation; Genotype; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunohistochemistry; Lamivudine; Virus Replication | 2001 |
Efficacy of lamivudine for the treatment of hepatitis B virus infection after liver transplantation in children.
Topics: 2-Aminopurine; Adolescent; Alanine Transaminase; Antiviral Agents; Child; Child, Preschool; Cystic Fibrosis; DNA, Viral; Famciclovir; Female; Hepatitis A; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Hyperoxaluria; Lamivudine; Liver Failure; Liver Transplantation; Living Donors; Male; Postoperative Complications; Retrospective Studies; Time Factors | 2001 |
Combination therapy for hepatitis B.
Topics: 2-Aminopurine; Antiviral Agents; Drug Therapy, Combination; Famciclovir; Forecasting; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine | 2002 |